ST-segment resolution as a marker for severe myocardial fibrosis in ST-segment elevation myocardial infarction

Qian Dong1, Xuesong Wen2, Guanglei Chang1

  • 1Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong, Chongqing, China.

BMC Cardiovascular Disorders
|September 22, 2021
PubMed

Insights

ST-segment resolution (STR) below 40.15% after percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI) patients predicts thicker myocardial scars. This finding aids in assessing scar extent post-PCI.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Interventional Cardiology

Background:

  • ST-segment elevation myocardial infarction (STEMI) requires timely intervention to limit myocardial damage.
  • Assessing myocardial scar extent after percutaneous coronary intervention (PCI) is crucial for patient prognosis.
  • ST-segment resolution (STR) is an early indicator of reperfusion success but its correlation with scar thickness needs further investigation.

Purpose of the Study:

  • To determine the relationship between ST-segment resolution (STR) and myocardial scar thickness following PCI in STEMI patients.
  • To evaluate the predictive value of STR for the development of transmural versus non-transmural myocardial scars.
  • To assess the association between STR and myocardial scar size.

Main Methods:

  • Forty-two STEMI patients undergoing PCI were studied.
  • ST-segment elevations were measured at admission and 24 hours post-PCI.
  • Late gadolinium-enhanced cardiac magnetic resonance imaging (CMR-LGE) assessed myocardial scar thickness and size 7 days post-PCI.

Main Results:

  • STR demonstrated high sensitivity (96%) and specificity (88%) in predicting transmural scars at a cutoff of 40.15%.
  • Patients with STR < 40.15% had a 170.90-fold increased likelihood of developing transmural scars.
  • STR percentage significantly correlated with myocardial scar thickness and size.

Conclusions:

  • An STR value below 40.15% at 24 hours post-PCI is a significant predictor of myocardial scar thickness in STEMI patients.
  • STR provides valuable diagnostic information for assessing the extent of myocardial scarification.
  • These findings can help refine risk stratification and management strategies for STEMI patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
134
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
47
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
84
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
47
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
423